Clinical Trials Update:&nbsp;Nov. 12, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
592462
roundup Plus: PC shipments up, but revenue less so, study says...BEA mobilizes corporate data...Web services outfits merge...Microsoft sets holiday Xbox bundle...PalmSource settles Digeo patent suit.
367540
WEDNESDAY, Dec. 8 (HealthDayNews) -- Two separate studies offer some good news about two drugs for the treatment of Parkinson's disease.
93775
Encouraging phase II results of a trial to test the efficacy of a malaria vaccine for young children is published in this week&#39;s issue of THE LANCET (pp 1380, 1411).
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
588883
roundup Plus: Rice lab makes nano parts less toxic...TV chip company gets $19 million...Oracle extends deadline on PeopleSoft bid...MLB sells game clips for 99 cents.
362077
Clinical trial data released by pharmaceutical company Boehringer Ingelheim at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, DC, on its experimental protease inhibitor tipranavir show that the drug is effective
95097
NEW YORK -- The pharmaceutical industry yesterday said it plans to publish more data about clinical drug trials, despite skepticism about whether the initiative will increase transparency and improve drug safety.
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
335462
Description: A consortium of leading medical journals wants to prevent publication of clinical trial results that overemphasize positive data.
113061
Pfizer Inc. PFE.N  said on Tuesday  its experimental drug for a deadly form of stomach cancer  proved safe and effective in a late-stage trial, prompting  researchers to halt the study seven months ahead of schedule.
417456
roundup Plus: .Mac customers suffer e-mail glitches...IBM launches business research group...Verbatim to make discs with HP labeling feature.
370141
FRIDAY, Jan. 11 (HealthDay News) -- Therapeutic vaccines to fight ovarian and breast cancer are in the first stage of clinical trials to determine their safety and effectiveness, researchers report.
511748
Northfield announces clinical trial results that investors can learn from.
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
671952
THURSDAY, Jan. 27 (HealthDayNews) -- The results of a multi-center trial involving a quartet of drugs may bring fresh hope to patients battling advanced colorectal cancer, researchers reported Thursday.
64788
Pfizer Inc. on Tuesday said its experimental drug for a deadly form of stomach cancer proved safe and effective in a late-stage trial, prompting researchers to halt the study seven months ahead of schedule.